• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 1010

Rebaudioside M obtained by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni)

Intended Use: Intended for use as a general-purpose sweetener in foods, excluding infant formula and meat and poultry products, at levels determined by good manufacturing practices.
Basis: Scientific procedures
Notifier: Manus Bio, Inc.
Notifier Address: 1030 Massachusetts Ave
Unit #300
Cambridge, MA 02138
GRAS Notice (releasable information): GRN 1010 (in PDF) (5.1 MB)
Date of closure: Jan 26, 2022
FDA's Letter: FDA has no questions (in PDF) (412 kB)